Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial
Merit Cudkowicz(Massachusetts General Hospital), Sarah Titus(Massachusetts General Hospital), Marianne Kearney(Massachusetts General Hospital), Hong Yu(Massachusetts General Hospital), Alexander Sherman(Massachusetts General Hospital), David Schoenfeld(Massachusetts General Hospital), Douglas Hayden(Massachusetts General Hospital), Amy M. Shui(Massachusetts General Hospital), Benjamin Rix Brooks(Carolinas Medical Center), Robin Conwit(National Institute of Neurological Disorders and Stroke), Donna Felsenstein(Massachusetts General Hospital), David J. Greenblatt(Tufts University), Myles Keroack(Elliot Hospital), John T. Kissel(The Ohio State University), Robert G. Miller(California Pacific Medical Center), Jeffrey Rosenfeld(University of California, San Francisco), Jeffrey D. Rothstein(Johns Hopkins University), Ericka Simpson(Methodist Hospital), Nina Tolkoff‐Rubin(Massachusetts General Hospital), Lorne Zinman(Sunnybrook Health Science Centre), Jeremy M. Shefner(SUNY Upstate Medical University)
Cited by 239
Abstract
Related Papers
No related papers found
Powered by citation graph analysis